-
oa The Effect of Intermittent Fasting on FOXO3 Expression, Proteasome Activity and Oxidative Stress in Obese Men: A Clinical Trial
- Source: Current Indian Science, Volume 3, Issue 1, Jan 2025, E2210299X400288
-
- 18 Apr 2025
- 03 Jul 2025
- 02 Oct 2025
Abstract
The escalation of metabolic imbalance in obesity not only diminishes lifespan but also accelerates the cellular and biomolecular mechanisms of aging. This study aimed to explore the effect of intermittent fasting on FOXO3 expression, proteasome activity, and oxidative stress in obesity as parameters that play a role in the aging molecular process.
A randomized clinical trial was conducted in Jakarta. The study enrolled 50 obese males, divided into a control group of 25 individuals and an intervention group of 25 individuals. Over the course of 8 weeks, the intervention group adhered to a 5:2 intermittent fasting regimen, fasting for two days each week, specifically on Mondays and Thursdays. The food intake was monitored through food records and analyzed using the NutriSurvey 2007 program. Prior to and following the intervention, whole blood samples were collected for the analysis of FOXO3 expression, proteasome activity, and oxidative stress, assessed by measuring carbonyl, reduced glutathione/GSH, and total antioxidant capacity.
The fasting group exhibited a lower consumption of complex carbohydrates, fats, and proteins compared to the control. Notably, there was a significant increase in FOXO3 expression and proteasome activity observed in the intermittent fasting group compared to the control. Furthermore, oxidative stress was mitigated in the intermittent fasting group, as evidenced by a decrease in carbonyl and an increase in GSH levels and total antioxidant capacity.
The 5:2 intermittent fasting over an 8-week period promotes increased FOXO3 expression and proteasome activity while reducing oxidative stress, thereby potentially delaying the aging process in obesity.
This study has been registered online at www.clinicaltrial.gov (ID: NCT04319133).
